Stereotactic Body Radiotherapy for Small Lung Tumors in the University of Tokyo Hospital

Stereotactic Body Radiotherapy for Small Lung Tumors in the University of Tokyo Hospital

Our work on stereotactic body radiation therapy (SBRT) for primary and metastatic lung tumors will be described. The eligibility criteria for SBRT, our previous SBRT method, the definition of target volume, heterogeneity correction, the position adjustment using four-dimensional cone-beam computed t...

Full description

Bibliographic Details
Main Authors:	Hideomi Yamashita, Wataru Takahashi, Akihiro Haga, Satoshi Kida, Naoya Saotome, Keiichi Nakagawa
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2014/136513

Similar Items

Evaluation of heterogeneity dose distributions for Stereotactic Radiotherapy (SRT): comparison of commercially available Monte Carlo dose calculation with other algorithms
by: Takahashi Wataru, et al.
Published: (2012-02-01)

Stereotactic Body Radiotherapy for Metastatic Lung Cancer as Oligo-Recurrence: An Analysis of 42 Cases
by: Wataru Takahashi, et al.
Published: (2012-01-01)

Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy
by: Wakui Reiko, et al.
Published: (2010-05-01)

Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison
by: Mami Ogita, et al.
Published: (2021-06-01)

Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI
by: Guofu Chen, et al.
Published: (2019-06-01)

Stereotactic body radiotherapy for central lung tumors, yes we can!
by: Yasmin Korzets ceder, et al.
Published: (2018-04-01)

Stereotactic body radiotherapy in lung cancer: an update
by: Carlos Eduardo Cintra Vita Abreu, et al.
Published: (2015-08-01)

Stereotactic Body Radiotherapy for the Treatment of Renal Tumors
by: Michael Hanzly, et al.
Published: (2014-09-01)

Complications from Stereotactic Body Radiotherapy for Lung Cancer
by: Kylie H. Kang, et al.
Published: (2015-06-01)

Treatment of Sarcoma Lung Metastases with Stereotactic Body Radiotherapy
by: Adam D. Lindsay, et al.
Published: (2018-01-01)

Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
by: Enrique Gutiérrez, et al.
Published: (2021-07-01)

Interfractional Variations of Tumor Centroid Position and Tumor Regression during Stereotactic Body Radiotherapy for Lung Tumor
by: Yanan Sun, et al.
Published: (2014-01-01)

Interfraction variation in lung tumor position with abdominal compression during stereotactic body radiotherapy
by: Mampuya Wambaka Ange
Published: (2014)

Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence
by: Tetsuya Inoue, et al.
Published: (2012-01-01)

Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors
by: Igaki Hiroshi, et al.
Published: (2007-06-01)

Stereotactic Body Radiotherapy for Centrally Located Non-small Cell Lung Cancer
by: Yuming WAN, et al.
Published: (2018-05-01)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
by: Caryn Wujanto, et al.
Published: (2019-11-01)

Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases
by: Goda G. Kalinauskaite, et al.
Published: (2020-05-01)

Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)

Respiratory gating during stereotactic body radiotherapy for lung cancer reduces tumor position variability.
by: Tetsuo Saito, et al.
Published: (2014-01-01)

Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma
by: Pu Zhou, et al.
Published: (2021-01-01)

Clinical experience with lung-specific electromagnetic transponders for real-time tumor tracking in lung stereotactic body radiotherapy
by: Maud Jaccard, et al.
Published: (2019-10-01)

Stereotactic body radiotherapy for pulmonary oligometastases as an initial metastasis‐directed therapy: patterns of relapse and predictive factors for early mortality
by: Takaya Yamamoto, et al.
Published: (2021-06-01)

Stereotactic Body Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer
by: Pawinee Mahasittiwat, et al.
Published: (2020-04-01)

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
by: Katrina Woodford, et al.
Published: (2017-10-01)

Feasibility Study of Automated Framework for Estimating Lung Tumor Locations for Target-Based Patient Positioning in Stereotactic Body Radiotherapy
by: Satoshi Yoshidome, et al.
Published: (2015-01-01)

A feasibility study of stereotactic radiosurgery/stereotactic body radiotherapy/stereotactic ablative radiotherapy practice using tomoedge in helical tomotherapy for lung, liver, and spine targets
by: N V. N. Madhusudhana Sresty, et al.
Published: (2021-01-01)

Palliative radiotherapy for gross hematuria in patients with advanced cancer
by: Mami Ogita, et al.
Published: (2021-05-01)

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors
by: Sebastian Regnery, et al.
Published: (2020-10-01)

A pilot study on the safety and efficacy of dose escalation in stereotactic body radiotherapy for peripheral lung tumors
by: Mitsuyoshi, Takamasa
Published: (2018)

Stereotactic Body Radiotherapy for Prostate Cancer
by: Neil R. Parikh M.D., et al.
Published: (2020-06-01)

Serious gastric perforation after second stereotactic body radiotherapy for peripheral lung cancer that recurred after initial stereotactic body radiotherapy: a case report
by: Hotaka Nonaka, et al.
Published: (2017-12-01)

Analyses of the local control of pulmonary Oligometastases after stereotactic body radiotherapy and the impact of local control on survival
by: Takaya Yamamoto, et al.
Published: (2020-10-01)

Stereotactic body radiotherapy improves the survival of patients with oligometastatic non‐small cell lung cancer
by: Wen Ouyang, et al.
Published: (2019-08-01)

Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy
by: Janvary Zsolt Levente, et al.
Published: (2017-05-01)

Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study.
by: Benjamin Mou, et al.
Published: (2014-01-01)

Dosimetric comparison of three-dimensional conformal radiotherapy, intensity modulated radiotherapy, and helical tomotherapy for lung stereotactic body radiotherapy
by: Rajesh Ashok Kinhikar, et al.
Published: (2015-01-01)

Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
by: Laila König, et al.
Published: (2020-02-01)

Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results
by: Ayakawa Shiho, et al.
Published: (2009-05-01)

Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.
by: Takaya Yamamoto, et al.
Published: (2018-01-01)